Short segment Barrett esophagus and specialized columnar mucosa at the gastroesophageal junction

Mayo Clinic Proceedings

Volumn 76, Issue 3, 2001, Pages 331-334

  Sharma, Prateek ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARRETT ESOPHAGUS; CANCER RISK; COLUMNAR EPITHELIUM; CONFERENCE PAPER; ESOPHAGOSCOPY; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; GASTROESOPHAGEAL REFLUX; HUMAN;

EID: 0035089808     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/76.3.331     Document Type: Conference Paper

References (36)

1. Skinner DB, Walther BC, Riddell RH, Schmidt H, lascone C, DeMeester TR. Barrett's esophagus: comparison of benign and malignant cases. Ann Surg. 1983; 198:554-565.
2. Sharma P, Morales TG, Sampliner RE. Short segment Barrett's esophagus-the need for standardization of the definition and of endoscopie criteria. Am J Gastroenterol. 1998;93:1033-1036.
3. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991:265:1287-1289.
4. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology. 1993;104:510-513.
5. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83:2049-2053.
6. Hirota WK, Loughney TM, Lazas DJ, Maydonovitch CL, Rholl V, Wong RK. Specialized intestinal metaplasia, dysplasia, and cancer
7. of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology. 1999;! 16:277-285.
8. Goldblum JR, Vicari JJ, Falk GW, et al. Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection. Gastroenterology. 1998;! 14:633639.
9. Oberg S, Peters JH, DeMeester TR, et al. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg. 1997;226:522-530.
10. McClave SA, Boyce HW Jr, Gottfried MR. Early diagnosis of columnar-lined esophagus: a new endoscopie diagnostic criterion. Gastrointest Endosc. 1987;33:413-416.
11. Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goyal RK. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet. 1994;344:1533-1536.
12. Weston AP, Krmpotich P, Makdisi WF, et al. Short segment Barren's esophagus: clinical and histological features, associated endoscopie findings, and association with gastric intestinal metaplasia. Am J Gastroenterol. 1996;91:981-986.
13. Johnston MH, Hammond AS, Laskin W, Jones DM. The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy. Am J Gastroenterol. 1996;91:1507-1511.
14. Morales TG, Sampliner RE, Bhattacharyya A. Intestinal metaplasia of the gastric cardia. Am J Gastroenterol. 1997;92:414-418.
15. Chalasani N, Wo JM, Hunter JG, Waring JP. Significance of intestinal metaplasia in different areas of esophagus including esophagogastric junction. Dig Dis Sei. 1997;42:603-607.
16. Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barren's) esophagus: comparison of population-based clinical and autopsy findings. Gastroenterology. 1990; 99:918-922.
17. Wallner B, Sylvan A, Stenling R, Janunger KG. The esophageal Zline appearance correlates to the prevalence of intestinal metaplasia. Scand J Gastroenterol. 2000;35:17-22.
18. Canto MI, Setrakian S, Willis J, et al. Méthylène blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barren's esophagus. Gastrointest Endosc. 2000;51:560-568.
19. Stevens PD, Lightdale CJ, Green PH, Siegel LM, GarciaCarrasquillo RJ, Rotterdam H. Combined magnification endoscopy with chromoendoscopy for the evaluation of Barren's esophagus. Gastrointest Endosc. 1994;40:747-749.
20. Clark GWB, Ireland AP, Peters JH, Chandrasoma P, DeMeester TR, Bremner CG. Short-segment Barren's esophagus: a prevalent complication of gastroesophageal reflux disease with malignant potential. J Gastrointest Surg. 1997;!: 113-122.
21. Loughney T, Maydonovitch CL, Wong RK. Esophageal manometry and ambulatory 24-hour pH monitoring in patients with short and long segment Barren's esophagus. Am J Gastroenterol. 1998;93:916-919.
22. Hamilton SR, Smith RR, Cameron JL. Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol. 1988; 19:942948.
23. Clark GW, Smyrk TC, Burdiles P, et al. Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg. 1994; 129:609614.
24. Cameron AJ, Lomboy CT, Pera M, Carpenter HA. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology. 1995; 109:1541-1546.
25. Schnell TG, Sontag SJ, Chejfec G. Adenocarcinomas arising in tongues or short segments of Barrett's esophagus. Dig Dis Sei. 1992;37:137-143.
26. Schnell T, Sontag SJ, Chejfec G, et al. Does more Barren's really mean more cancer? comparison of incidence rates (IR) of adenocarcinoma (ADCA) in prospectively followed patient (PT) cohorts with short (SSBE) and long (LSBE) segments of Barrett's esophagus (BE) [abstract]. Gastroenterology. 1998;! 14:A674. Abstract G2783.
27. Sharma P, Morales TG, Bhattacharyya A, Garewal HS, Sampliner RE. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up. Am J Gastroenterol. 1997;92:2012-2016.
28. Rudolph RE, Vaughan TL, Storer BE, et al. Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus. Ann Intern Med. 2000; 132:612-620.
29. Spechler SJ. The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction. Gastroenterology. 1999;! 17:218228.
30. Sharma P. Recent advances in Barrett's esophagus: short-segment Barrett's esophagus and cardia intestinal metaplasia. Semin GastrointestDis. 1999;10:93-102.
31. Jain R, Aquino D, Harford WV, Lee E, Spechler SJ. Frequency of intestinal metaplasia at different sites in the esophagus and stomach [abstract]. Gastroenterology. 1998;! 14:A160. Abstract G0655.
32. Genta RM, Huberman RM, Graham DY. The gastric cardia in Helicobacter pylori infection. Hum Pathol. 1994;25:915-919.
33. Sharma P, Weston AP, Morales T, Topalovski M, Mayo MS, Sampliner RE. Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia. Gut. 2000;46:9-13.
34. Pereira AD, Suspiro A, Chaves P, et al. Short segments of Barren's epithelium and intestinal metaplasia in normal appearing oesophagogastric junctions: the same or two different entities? Gut. 1998; 42:659-662.
35. Hackelsberger A, Günther T, Schultze V, et al. Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease? Gut. 1998;43:17-21.
36. Ormsby AH, Goldblum JR, Rice TW, et al. Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach. Hum Pathol. 1999;30:288-294.